Markets & Regulations

(mikkelwilliam/iStock via Getty Images Plus)

People on the Move: July 2021

By Jenni Spinner

This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.

(Thaweesak Saengngoen/iStock via Getty Images Plus)

Recent FDA COVID-19 actions and updates

By Jenni Spinner

The agency has been busy with actions related to the virus behind the pandemic, keeping an eye on vaccinations, emerging variants, and other concerns.

(Who_I_am/iStock via Getty Images Plus)

Tech Innovations: June 2021

By Jenni Spinner

This month’s roundup of new equipment, materials, tech partnerships and other news includes items from Ajinomoto, Evonik, Quanticate, Pharmasol, and more.

Pic:getty/CG6images

FDA approves Biogen’s Alzheimer's drug, Aduhelm

By Rachel Arthur

The US Food and Drug Administration (FDA) has approved Biogen’s Aduhelm (aducanumab) for the treatment of Alzheimer’s: making it the first new treatment approved for the disease since 2003.

Follow us

Products

View more

Webinars